Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 211-216

  Igarashi, Tatsuhiko ^a   Brown, Charles ^a   Azadegan, Ali ^b   Haigwood, Nancy ^c   Dimitrov, Dimiter ^d   Martin, Malcolm A ^a   Shibata, Riri ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e VaxGen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FREE SYSTEM; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS TITRATION;

ANIMALS; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV-1; HUMANS; MACACA MULATTA; MACACA NEMESTRINA; NEUTRALIZATION TESTS; PAN TROGLODYTES; VIRAL LOAD; VIREMIA; VIRION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA;

EID: 0032905728     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5576     Document Type: Article

References (28)

1. Mellors, J.W. et al. Prognosis in HIV-1 predicted by the quantity of virus in plasma. Science 272, 1167-1170 (1996).
2. Nathanson N. and Harrington B. Experimental Infection of Monkeys with Langat Virus. II. Turnover of Circulating Virus. Am. J. Epidemiol. 85, 494-502 (1967).
3. Shibata, R. et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65, 3514-3520 (1991).
4. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K. & Adachi, A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76, 2723-2730 (1995).
5. Himathongkham, S. & Luciw, P.A. Restriction of HIV-1 (Subtype B) replication at the early step in rhesus macaque cells. Virology 219, 485-488 (1996).
6. Igarashi, T. et al. Protection of monkeys vaccinated with vpr and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine. J. Gen. Virol. 78, 985-989 (1997).
7. Agy, M.B. et al. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 103, 103-106 (1992).
8. Shibata, R. et al. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J. Virol. 69, 4453-4462 (1995).
9. Shibata, R. et al. Infection and Pathogenicity of Chimeric SIV/HIV Viruses in Macaques; Determinants of High Virus Loads and CD4 cell Killing. J. Infect. Dis. 176, 362-373 (1997)
10. Li, J., Lord, C.I., Haseltine, W., Letvin, N.L. & Sodroski, J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. AIDS. 5, 639-646 (1992).
11. Zilversmit, D.B., Boyd, G.A. & Brucer, M. The effect of particle size on blood clearance and tissue distribution of radioactive gold colloids. J. Lab. Clin. Med. 40, 255-266 (1952).
12. Shibata, R. et al. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70, 4361-4369 (1996).
13. Brunner, K.T., Hurez, D., McCluskey, R.T. & Benacerraf, B. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. J. Immunol. 85, 99-105 (1960).
14. Mims, C.A. Rift valley fever virus in mice. II. Adsorption and multiplication of virus. Brit. J. Exp. Pathol. 37, 110-119 (1956).
15. Mims, C.A The response of mice to large intravenous injections of Ectromelia virus II. The growth of virus in the liver. Brit. J. Exp. Pathol. 40, 533-542 (1959).
16. Schultz, I. & Neva, F.A. Relationship between blood clearance and viruria after intravenous injection of mice and rats with bacteriophage and poliovirus. J. Immunol. 94, 833-841 (1965).
17. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122 (1995).
18. Ho, D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126 (1995).
19. Perelson, A. et al. HIV-1 Dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586 (1996).
20. National Institutes of Health in Guide for the Core and Use of Laboratory Animals, revised ed. DHHS publication number NIH 85-23 (1985).
21. Naidu Y.M. et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62, 4691-4696 (1988).
22. Adachi A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291 (1986).
23. Shibata, R. et al. Reactivation of HIV Type 1 in chronically infected chimpanzees following xenostimulation with human cells or with pulses of corticosteroid. Aids Res. Hum. Retroviruses. 13, 377-381 (1997).
24. Haigwood, N.L. et al. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol. Lett. 51, 107-114 (1996).
25. Shibata, R., Siemon, C., Czajak, S.C., Desrosiers, R.C. & Martin, M.A. Live attenuated SIV vaccines elicit potent resistance against a challenge with an HIV-1 chimeric virus. J. Virol. 71, 8141-8148 (1997).
26. Willey R.L. et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62, 139-147 (1988).
27. Reed, L.J. & Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497 (1938).
28. Dewar, R.L. et. al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170, 1172-1179 (1994).